CD19 and systemic sclerosis: Mature naïve B cells (CD19+CD21+CD10−IgM+CD27−) producing Hep-2-reactive antibodies were also increased in SSc patients compared to healthy donors suggesting an additional defective peripheral B cell tolerance checkpoint.